The fourth commitment of the weekend for Purdue football comes from a recruit who was scheduled to be on a different program's campus. Dream Rashad, a 6-foot-6, 230-pounder from Lawrenceville ...

Explore daily insights on the USA TODAY crossword puzzle by . Uncover expert takes and answers in our crossword blog.

Ten CFR experts break down what the president’s trade agenda has accomplished since he placed a ninety-day pause on his expansive “Liberation Day” tariffs.

Thanks to new settlements with opioid manufacturers, Michigan will get $178.5 million more for its drug fight. But is it enough?

If your email was hacked, review what kind of content was visible in your email. Ex: Is there sensitive or personal information visible such as PUID, SSN, bank information, invoice information, or ...

Washington Post columnist Jonathan Capehart has accepted a buyout from the paper, becoming the latest high-profile departure amid sweeping editorial changes implemented under owner Jeff Bezos ...

Sandwich chain Subway on Monday named former Burger King executive Jonathan Fitzpatrick as its CEO starting July 28, tapping a fast-food industry veteran to lift sales and help expand its business ...

RALEIGH, N.C. (WNCN) — Just over a month after Attorney General Jeff Jackson announced North Carolina would receive more than $100 million in the Purdue Pharma opioid settlement, North Carolina First ...

Jonathan Rose raises $660M for affordable housing climate fund Rose bets on affordable housing, impact fund amid wave of ESG backlash ...

Subway named a former Burger King executive as its next chief executive, with a mandate to improve U.S. sales and help expand globally. Jonathan Fitzpatrick is set to become Subway’s first new ...

Alaska is set to receive up to $12.2 million over the next 15 years after signing onto a settlement with Purdue Pharma and the Sackler family The Sacklers’ former company, Purdue Pharma, made ...

Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding unexpectedly well to treatment.